Cargando…

A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells

Dendrimers are hyperbranched macromolecules with well-defined topological structures and multivalent functionalization sites, but they may cause cytotoxicity due to the presence of cationic charge. Recently, we have introduced alkyne-terminated poly(amidoamine) (PAMAM) dendrons of different generati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yanfang, Li, Jiemei, Lu, Fang, Deng, Junjie, Zhang, Jiahua, Fang, Peijie, Peng, Xinsheng, Zhou, Shu-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437608/
https://www.ncbi.nlm.nih.gov/pubmed/25999697
http://dx.doi.org/10.2147/DDDT.S77105
_version_ 1782372236710117376
author Zhou, Yanfang
Li, Jiemei
Lu, Fang
Deng, Junjie
Zhang, Jiahua
Fang, Peijie
Peng, Xinsheng
Zhou, Shu-Feng
author_facet Zhou, Yanfang
Li, Jiemei
Lu, Fang
Deng, Junjie
Zhang, Jiahua
Fang, Peijie
Peng, Xinsheng
Zhou, Shu-Feng
author_sort Zhou, Yanfang
collection PubMed
description Dendrimers are hyperbranched macromolecules with well-defined topological structures and multivalent functionalization sites, but they may cause cytotoxicity due to the presence of cationic charge. Recently, we have introduced alkyne-terminated poly(amidoamine) (PAMAM) dendrons of different generations (G=2,3) into chitosan to obtain dendronized chitosan derivatives [Cs-g-PAMAM (G=2,3)], which exhibited a better water solubility and enhanced plasmid DNA transfection efficiency. In this study, we attempted to examine the impact of Cs-g-PAMAM (G=2,3) at different concentrations (25 μg/mL, 50 μg/mL, and 100 μg/mL) on the morphology, surface structure, and viability of rat red blood cells (RBCs). The results showed that treatment of RBCs with Cs-g-PAMAM (G=2,3) at 50 μg/mL and 100 μg/mL induced a slightly higher hemolysis than Cs, and Cs-g-PAMAM (G=3) caused a slightly higher hemolysis than Cs-g-PAMAM (G=2), but all values were <5.0%. Optical microscopic and atomic force microscopic examinations indicated that Cs-g-PAMAM (G=2,3) caused slight RBC aggregation and lysis. Treatment of RBCs with 100 μg/mL Cs-g-PAMAM (G=3) induced echinocytic transformation, and RBCs displayed characteristic irregular contour due to the folding of the periphery. Drephanocyte-like RBCs were observed when treated with 100 μg/mL Cs-g-PAMAM (G=3). Erythrocytes underwent similar shape transition upon treatment with Cs-g-PAMAM (G=2) or Cs. The roughness values (Rms) of RBCs incubated with Cs-g-PAMAM (G=2,3) were significantly larger than those for RBCs incubated with physiological saline (P<0.01), but the Rms showed no difference for Cs and Cs-g-PAMAM (G=2,3) (P>0.05). Furthermore, Cs-g-PAMAM (G=2,3) exhibited a lower cytotoxicity in human kidney 293T cells. These results indicate that Cs-g-PAMAM (G=2,3) are hemocompatible but may disturb membrane and lipid structures at higher concentrations. Further safety and biocompatibility evaluations are warranted for Cs-g-PAMAM. Our findings prove helpful for a better understanding of the advantages of combining PAMAM dendrimers and chitosan to design and develop new, safe, and effective drug delivery vehicles.
format Online
Article
Text
id pubmed-4437608
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44376082015-05-21 A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells Zhou, Yanfang Li, Jiemei Lu, Fang Deng, Junjie Zhang, Jiahua Fang, Peijie Peng, Xinsheng Zhou, Shu-Feng Drug Des Devel Ther Original Research Dendrimers are hyperbranched macromolecules with well-defined topological structures and multivalent functionalization sites, but they may cause cytotoxicity due to the presence of cationic charge. Recently, we have introduced alkyne-terminated poly(amidoamine) (PAMAM) dendrons of different generations (G=2,3) into chitosan to obtain dendronized chitosan derivatives [Cs-g-PAMAM (G=2,3)], which exhibited a better water solubility and enhanced plasmid DNA transfection efficiency. In this study, we attempted to examine the impact of Cs-g-PAMAM (G=2,3) at different concentrations (25 μg/mL, 50 μg/mL, and 100 μg/mL) on the morphology, surface structure, and viability of rat red blood cells (RBCs). The results showed that treatment of RBCs with Cs-g-PAMAM (G=2,3) at 50 μg/mL and 100 μg/mL induced a slightly higher hemolysis than Cs, and Cs-g-PAMAM (G=3) caused a slightly higher hemolysis than Cs-g-PAMAM (G=2), but all values were <5.0%. Optical microscopic and atomic force microscopic examinations indicated that Cs-g-PAMAM (G=2,3) caused slight RBC aggregation and lysis. Treatment of RBCs with 100 μg/mL Cs-g-PAMAM (G=3) induced echinocytic transformation, and RBCs displayed characteristic irregular contour due to the folding of the periphery. Drephanocyte-like RBCs were observed when treated with 100 μg/mL Cs-g-PAMAM (G=3). Erythrocytes underwent similar shape transition upon treatment with Cs-g-PAMAM (G=2) or Cs. The roughness values (Rms) of RBCs incubated with Cs-g-PAMAM (G=2,3) were significantly larger than those for RBCs incubated with physiological saline (P<0.01), but the Rms showed no difference for Cs and Cs-g-PAMAM (G=2,3) (P>0.05). Furthermore, Cs-g-PAMAM (G=2,3) exhibited a lower cytotoxicity in human kidney 293T cells. These results indicate that Cs-g-PAMAM (G=2,3) are hemocompatible but may disturb membrane and lipid structures at higher concentrations. Further safety and biocompatibility evaluations are warranted for Cs-g-PAMAM. Our findings prove helpful for a better understanding of the advantages of combining PAMAM dendrimers and chitosan to design and develop new, safe, and effective drug delivery vehicles. Dove Medical Press 2015-05-14 /pmc/articles/PMC4437608/ /pubmed/25999697 http://dx.doi.org/10.2147/DDDT.S77105 Text en © 2015 Zhou et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhou, Yanfang
Li, Jiemei
Lu, Fang
Deng, Junjie
Zhang, Jiahua
Fang, Peijie
Peng, Xinsheng
Zhou, Shu-Feng
A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
title A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
title_full A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
title_fullStr A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
title_full_unstemmed A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
title_short A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
title_sort study on the hemocompatibility of dendronized chitosan derivatives in red blood cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437608/
https://www.ncbi.nlm.nih.gov/pubmed/25999697
http://dx.doi.org/10.2147/DDDT.S77105
work_keys_str_mv AT zhouyanfang astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT lijiemei astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT lufang astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT dengjunjie astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT zhangjiahua astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT fangpeijie astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT pengxinsheng astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT zhoushufeng astudyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT zhouyanfang studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT lijiemei studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT lufang studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT dengjunjie studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT zhangjiahua studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT fangpeijie studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT pengxinsheng studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells
AT zhoushufeng studyonthehemocompatibilityofdendronizedchitosanderivativesinredbloodcells